---
document_datetime: 2023-09-21 20:11:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cystadrops-epar-all-authorised-presentations_en.pdf
document_name: cystadrops-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7420242
conversion_datetime: 2025-12-28 04:22:59.893042
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                                   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------------------------------------------------------|
| EU/1/15/1049/001 | Cystadrops        | 3.8 mg/ml  | Eye drops, solution   | Ocular use                | vial (glass)          | 5 ml                      | 1 vial + 1 dropper applicator                               |
| EU/1/15/1049/002 | Cystadrops        | 3.8 mg/ml  | Eye drops, solution   | Ocular use                | vial (glass)          | 5 ml                      | 4 (4 x 1) vials + 4 (4 x 1) dropper applicators (multipack) |